Month: July 2025

Image Credit: Adobe Stock Images/PeopleGraphics.com As the month of July winds down, the trade wars featuring the United States versus all other nations have been in full swing for about six months now. This had been kicked off by President Trump’s Feb. 1 decision to impose 25% tariffs on Mexican and Canadian imports—along with 10% […]

With there being challenges in analyzing OOPCs that were related to certain cancer diagnoses in patients that privately insured, a retrospective cohort study published in JAMA Network Open sought toinvestigate this further. Image Credit: Adobe Stock Images/CDavids/peopleimages.com It is no secret that the out-of-pocket costs (OOPCs) associated with cancer care in the United States can […]

In a video interview with Pharma Commerce, Nate Chenenko, principal with Ducker Carlisle, sheds light on the critical issue of Scope 3 emissions and their growing relevance in the pharmaceutical industry, particularly across warehousing, packaging, and outbound transportation. Chenenko defines Scope 3 emissions as all indirect emissions that occur after a pharmaceutical product is manufactured. […]

President Trump reached a formal trade agreement with the European Union in which a maximum 15% levy will be imposed on “most” EU exports, including autos and their parts; semiconductors; and pharmaceuticals. Image Credit: Adobe Stock Images/RealisticAIStudio.com Earlier this week, per CBS News, President Trump reached a formal trade agreement with the European Union in […]

In a video interview with Pharma Commerce, Hyung Heon Kim, CEO of MetaVia, describes how the current US payer ecosystem, including commercial insurers and Medicaid, exhibits a divided approach when it comes to supporting access to obesity medications. Coverage largely depends on whether obesity is accompanied by additional health complications. He explains that there are […]

In a video interview with Pharma Commerce, Nate Chenenko, principal with Ducker Carlisle, sheds light on the critical issue of Scope 3 emissions and their growing relevance in the pharmaceutical industry, particularly across warehousing, packaging, and outbound transportation. Chenenko defines Scope 3 emissions as all indirect emissions that occur after a pharmaceutical product is manufactured. […]

PC: As CGTs expand to serve broader patient populations, what strategies can developers use to overcome market access barriers such as payer skepticism and limited reimbursement pathways? Kevin Chinn: Central to overcoming the challenges is the need to increase payer awareness of the product’s clinical and economic value, including its safety, efficacy and durability. Conducting […]

The controversy surrounding embattled gene therapy company Sarepta Therapeutics, including its drug, Elevidys, for Duchenne muscular dystrophy, continues to captivate industry observers—with the latest twist being Sarepta’s decision late Monday to voluntarily pause Elevidys shipments in the US. Monday’s action marked an about-face by the company from just a few days earlier, when it rejected […]

In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes how a proposed 200% tariff on pharmaceutical imports could have significant short- and long-term impacts on US drug manufacturing and distribution, with immediate concerns focused on the stability of the generic drug market. According to Stewart, generic drugs make up […]

In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes how a proposed 200% tariff on pharmaceutical imports could have significant short- and long-term impacts on US drug manufacturing and distribution, with immediate concerns focused on the stability of the generic drug market. According to Stewart, generic drugs make up […]

Sixty percent of life sciences and healthcare leaders are anticipating that the current or forthcoming tariffs and pricing policies will have “some impact” on their businesses. Image Credit: Adobe Stock Images/Thanawat_Suesoypan.com According to the Deloitte Center for Health Solutions’ “2025 Tariffs, Pricing, and Taxes Survey,”1 60% of life sciences and healthcare leaders are anticipating that […]

Image Credit: Adobe Stock Images/Sardar Key Takeaways Expanded Educational Access: Cold Chain Technologies (CCT) partners with E&I Cooperative Services to provide over 6,000 educational institutions expedited access to advanced cold chain packaging solutions. Streamlined Procurement Process: The partnership enables members to bypass lengthy RFP procedures, accelerating acquisition of temperature-controlled packaging for medical, scientific, and health […]

In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply chain, highlighting its complexity and importance in delivering medications safely and efficiently from manufacturers to patients. The conversation explored the roles of various stakeholders, the need for supply chain resilience and quality control, […]

Patient safety and medication adherence are some of the major concerns in the pharmaceutical industry. With an increase in medication errors, counterfeit medicines, and supply chain mismanagement, the industry has seen a rising demand for transparency, security, engagement, and digitization.1 Smart packaging has emerged as a key solution to address these problems by integrating digital […]

Balancing DEI Reporting with Legal Risk In an interview with Applied Clinical Trials, Kate Gallin Heffernan, a life sciences attorney at Epstein Becker Green, discussed how clinical research teams can balance accurate DEI-related reporting with minimizing legal risk, emphasizing the need for careful language and documentation to avoid potential False Claims Act exposure amid evolving […]

In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes how a proposed 200% tariff on pharmaceutical imports could have significant short- and long-term impacts on US drug manufacturing and distribution, with immediate concerns focused on the stability of the generic drug market. According to Stewart, generic drugs make up […]

The European Union intends to impose a 30% tariff on US imports valued at $117 billion if a trade deal is not reached. Image Credit: Adobe Stock Images/Khwankhae.com The European Union intends to impose a 30% tariff on US imports valued at $117 billion if a trade deal is not reached, and if President Trump […]